| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8a3f5a0bf829b1fa4b8a24f9d9125f7e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-24134
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-24122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-70 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12 |
| filingDate |
2014-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae9eac1017608d43c811f9c873a280c4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3669577bb22af5937029d570181103a4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0049a2b8650317e9a2251b000898e350 |
| publicationDate |
2015-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2015019253-A2 |
| titleOfInvention |
Anti-dengue virus genetic vaccine based on the envelope protein ectodomains |
| abstract |
The present invention refers to a genetic vaccine for dengue virus of all serotypes or for any virus belonging to the Flavivirus genus. Said vaccine is based on the envelope protein E ectodomains, more in particular on the DIII domain of dengue virus or of other Flavivirus. A genetic construct encoding a fusion protein wherein said domain of envelope protein E is fused to a carboxyterminal domain from the constant region of an immunoglobulin is disclosed in the present invention. The use of said construct allows for an efficient secretion of the fusion protein from the cells and thus for a high antibody response. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11666649-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021026372-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017079625-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108503696-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018071405-A1 |
| priorityDate |
2013-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |